Alternatives to Exoscient

Atomwise uses AI to accelerate the discovery of novel small molecule therapeutics with its AtomNet platform.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Global life sciences company providing diagnostic and biopharma laboratory services.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Leveraging the adaptive immune system to diagnose and treat disease.

Develops a computational model of the human body for drug discovery and development.

R&D cloud platform for life sciences, enabling scientific innovation and productivity.

A global oncology company developing and commercializing innovative cancer treatments.

AI-powered spatial biology platform for precision medicine and drug development.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

AI-powered platform for designing novel molecular structures for new medicines.

Lunit is a medical AI company developing AI-powered solutions for cancer diagnostics and therapeutics.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Leveraging AI and a massive patient tissue dataset to accelerate drug discovery and advance precision medicine.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.